Restorative Therapies, Inc., advances its New Era in Treatment for Neurological Injury and Paralysis.
Restorative Therapies, Inc., a designer of medical devices, today announced FDA clearance of Unilateral Stimulation for its successful medical device, the RT300
(www.restorative-therapies.com), is a privately-held company headquartered in Baltimore, Md., whose mission is to help people with neurological impairment achieve their full recovery
potential. Restorative Therapies is one of the first companies to target activity-based therapy and FES as a treatment for immobility associated with paralysis such as stroke, multiple
sclerosis and spinal cord injury. For further information please call 800 609-9166.
About Dr. John McDonald
John W. McDonald, MD, PhD, directs the International Center for Spinal Cord Injury at Kennedy Krieger Institute. From 1998-2004, prior to joining Kennedy Krieger, he founded and served as
director of the Spinal Cord Injury Program at Washington University School of Medicine in St. Louis. His clinical and scientific work has been recognized by many organizations, including
the National Institutes of Health, International Neurotrauma Society and American Academy of Neurology.